相关实验视频
Updated: Jan 28, 2026

Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
纳米疗法向miR-10b改善了正极形质母细胞瘤模型中的生存率
Bryan D Kim1,2, Ming Chen1,3, Sujan K Mondal1,3
1Precision Health Program, Michigan State University, East Lansing, MI 48824, USA.
磁性纳米粒子提供抗微型RNA-10b反感性寡核酸来治疗质母细胞瘤. 这种新的方法在临床前模型中提高了生存率和目标抑制,为侵袭性脑癌提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后和高复发率的侵袭性脑癌.
- 目前的治疗方法有限,需要新的治疗策略.
- 微RNA-10b (miR-10b) 是GBM进展的关键驱动因素,也是潜在的治疗点.
研究的目的:
- 开发和评估一种用于GBM治疗的抗miR-10b反感性寡核酸 (ASO) 的新型输送系统.
- 克服与ASO传递相关的挑战,包括短半衰期,核酶降解和血脑屏障 (BBB) 透.
- 在临床前的GBM模型中评估磁性纳米颗粒输送的抗miR-10b (MN-anti-miR10b) 的治疗疗效.
主要方法:
- 开发磁纳米颗粒 (MNs) 用于封装抗miR-10b ASOs.
- 在体内给药MN-anti-miR10b和TTX-MC138 (临床测试的抗miR-10b纳米治疗药物) 在正位体GBM模型中.
- 使用磁共振成像 (MRI) 监测纳米粒子输送.
- 对治疗结果的评估,包括生存,目标抑制和亡.
主要成果:
- MN-anti-miR10b对GBM瘤进行了有效的治疗,由MRI证实.
- 两种MN-anti-miR10b和TTX-MC138配方在GBM模型中显著改善了生存率.
- 治疗干预导致有效的miR-10b目标抑制和瘤细胞亡的增加.
- 磁性纳米粒子平台促进了治疗和非侵入性监测.
结论:
- 通过磁纳米粒子介导的抗miR-10b ASO的输送是GBM治疗的有前途的策略.
- 这种方法克服了关键的治疗障碍,提高了治疗疗效和患者的存活率.
- 针对性输送,成像和治疗的结合为质母细胞瘤提供了一个新的治疗范式.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
相关概念视频
Survival Tree
Building a Survival Tree
Constructing a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Censoring Survival Data